{
"NDC": {
"NDCCode": "58657-820-01",
"PackageDescription": "100 TABLET in 1 BOTTLE (58657-820-01) ",
"NDC11Code": "58657-0820-01",
"ProductNDC": "58657-820",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Doxazosin",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Doxazosin",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20220601",
"EndMarketingDate": "20231231",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212727",
"LabelerName": "Method Pharmaceuticals, LLC",
"SubstanceName": "DOXAZOSIN MESYLATE",
"StrengthNumber": "1",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2024-01-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": "20220601",
"EndMarketingDatePackage": "20231231",
"SamplePackage": "N"
}
}